Bruce Japsen

Children's Memorial Hospital confirmed plans to sell a for-profit disease and health cost management subsidiary for $89 million in its search for ways to finance its proposed new hospital in...

Once again, the American Medical Association will consider backing a government moratorium on pharmaceutical advertising to consumers. The largest U.S. doctor group will ask its members at its annual meeting...

Private equity firm Water Street Capital Partners' $50 million investment in a New Jersey pathology company helps maintain the Chicago area's reputation as a major source for the health-care industry's...

Although it will be five to six years before Children's Memorial Hospital officially leaves its current location in Lincoln Park, speculation in the neighborhood has begun to emerge on interested...

TAP Pharmaceutical Products Inc. is joining some other drugmakers in reinstating programs that provide free or discounted prescriptions to elderly Americans who do not sign up for the new Medicare...

With much at stake in this year's congressional elections, it appears the nation's dentists want to be in an influential position in the fall voting, a federal election campaign watchdog's...

Biotech company Neopharm Inc. continues to gather a body of evidence that supports the efficacy of its experimental brain tumor-shrinking drug, a treatment the company says could go before the...

The head of research and development for Baxter International Inc.'s vaccines business said that in the next two weeks the company will begin manufacturing more than two million doses of...

A rival prescription to a Lake Forest drugmaker's blockbuster prostate cancer drug could resume sales as early as next month after a brief hiatus brought on by a patent fight....

The federal government and a French bank will have two chances to recoup damages in separate civil lawsuits alleging fraud against the former top executive of now-defunct Edgewater Medical Center....